Multi-Component Neuroprotective Formulations for Trauma
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical interventions lack effective solutions to prevent or reduce the development of neuropathology and neurodegeneration resulting from traumatic injuries, which can lead to life-long adverse health conditions and disabilities, particularly in the central nervous system, spinal cord, and peripheral nervous system.
Innovation Solution
Multi-component formulations combining anticonvulsant/antiepileptic compounds, neurosteroids/neuroactive steroids, NK-1 receptor antagonists, and lithium-related compounds are administered to prevent or reduce the risk of neuropathology, targeting various routes of administration and timing post-trauma to arrest degenerative cascades and promote restorative processes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multi-component formulations are administered, then neuroprotective benefits are improved, but formulation complexity increases
Solution Approach 1:
The patent combines multiple pharmacologically active compounds (anticonvulsants, neurosteroids, NK-1 receptor antagonists, and lithium-related compounds) into a single multi-component formulation. This merging approach allows simultaneous delivery of multiple neuroprotective agents that target different pathological mechanisms, thereby improving overall neuroprotective benefits while managing formulation complexity through integrated design
Solution Approach 2:
The formulation employs composite material principles by creating a multi-phase system containing different types of compounds with varying solubility and pharmacokinetic properties. This composite approach enables the formulation to address multiple pathological pathways simultaneously (excitotoxicity, oxidative stress, inflammation) while maintaining stability and deliverability through carefully engineered material composition
2Reliability
If multiple compounds are combined in formulations, then therapeutic effectiveness is improved, but manufacturing complexity increases
Solution Approach 1:
The manufacturing process is segmented into distinct operational phases: (1) preparation of individual compound solutions or suspensions, (2) sequential or simultaneous mixing of components under controlled conditions, (3) formulation into final dosage forms, and (4) quality control testing. This segmentation allows each manufacturing step to be optimized independently, improving therapeutic effectiveness through precise control while managing overall manufacturing complexity through systematic process organization
Solution Approach 2:
The formulation employs parameter changes in pH, temperature, and solvent composition to optimize the stability and solubility of each compound component during manufacturing. By adjusting these parameters systematically, the patent achieves effective combination of multiple compounds with different physicochemical properties, thereby improving therapeutic effectiveness while maintaining manufacturing feasibility through controlled parameter optimization
Data Source
AI summary
Novel multi-component formulations, procedures and methods for use in treating neuropathology and neurodegeneration incident to trauma are provided. Multi-component formulations of the invention comprise biologically active forms of any two, any three, or all four of at least one neurosteroid or neuroactive steroid, such as progesterone or synthetic progestin, at least one anti-epileptic or anticonvulsant, such as gabapentin, pregabalin or valproic acid, at least one NK-1 receptor antagonist, such as aprepitant, casopitant or vestipitant, at least one lithium-containing or lithium-related drug. The provided formulations are configured or adapted to prevent or reduce the incidence and severity of neurological damage caused by trauma, or the risk of such damage. Formulations, procedures and methods of the invention advantageously effect both neuroprotective actions to prevent or reduce secondary injuries, and neurotrophic actions to repair and restore cells and tissues affected by the trauma, and are especially useful in treating injury or trauma to nerve cells, to neural support cells and to neural support tissues.